When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast…
Category:
Investing
-
-
-
-
Investing
Lundin Mining Declares Filo del Sol a “Generational” Discovery, One of the World’s Largest
by adminby adminLundin Mining (TSX:LUN,OTC Pink:LUNMF) has released an initial resource estimate for the Filo del Sol sulfide deposit, as well as updated resources for…
-
Investing
Group Eleven Intersects 12.0m of 2.30% Cu and 560 g/t Ag, Including 6.4m of 3.72% Cu and 838 g/t Ag, Demonstrating High-Grade Copper and Silver Potential at Ballywire
by adminby adminGroup Eleven Resources Corp. (TSXV: ZNG) (OTC Pink: GRLVF) (FSE: 3GE) (‘Group Eleven’ or the ‘Company’) is pleased to announce assay results from…
-
Investing
SAGA Metals Extends Claims at the Radar Ti-V-Fe Project –Securing the Entire Titanomagnetite-Bearing Intrusion
by adminby adminSaga Metals Corp. (‘SAGA’ or the ‘Company’) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H) a North American exploration company specializing in the discovery of…
-
Investing
Triumph Gold: Multi-million-ounce, District-scale Gold Assets in the Yukon Territory
by adminby adminTriumph Gold (TSXV:TIG,OTC:TIGCF) is a Canadian gold exploration company well-positioned to benefit from a strengthening gold market. The company’s primary focus is advancing…
-
-
-
Investing
Joe Cavatoni: Gold’s Record Run No Surprise, Here’s What’s Driving Demand
by adminby adminJoe Cavatoni, senior market strategist, Americas, at the World Gold Council, discusses the organization’s latest report on gold demand trends, highlight key data…